However, most symptoms decline in prevalence by 12 months
Females, Some Minorities Underrepresented in COVID-19 Clinical Trials
Females underrepresented in treatment trials, while Asian, Black participants underrepresented in prevention trials
Post-COVID-19 Syndrome Triples Use of Further Health Care Services
Female sex and high BMI associated with an increased risk for post-COVID-19 syndrome
Moderna, Merck Report on Promising Melanoma Vaccine
Companies announced that the vaccine performed well in a small study of patients who had the cancer surgically removed
U.S. Health Officials Urge Indoor Masking in Major Cities as ‘Tripledemic’ Rages
During the past few weeks, COVID-19, the flu, and respiratory syncytial virus have made millions of Americans ill
Preprint, Peer-Reviewed Pairs of Studies Generally Concordant
Sample sizes, primary end points, interpretations mainly concordant for studies published on medRxiv, then in journals
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Utilization of Telehealth Low in Ophthalmology
However, asynchronous testing may augment teleophthalmology
Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
Fully Online College Classes Tied to Greater Psychological Distress
Findings seen among U.S. undergraduate students during 2021 spring semester